Village People singer defends Trump's use of 'Y.M.C.A.,' says song isn't a 'gay anthem'January 17, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against WOLF
Rudy Giuliani in a courtroom outburst accuses judge in assets case of being unfair, drawing a rebuke
None
49ers rule out Brock Purdy and Nick Bosa; QB Brandon Allen to start at Green BayChina is looking to challenge the U.S. in artificial intelligence. China's tech giants have launched their own AI models. Niphon | Istock | Getty Images China's race to develop smarter-than-human artificial intelligence may put it ahead of the U.S., but such ground-breaking technology could also risk lessening the stronghold that the ruling Communist Party has over the world's second-largest economy. That's the view of prominent AI scientist Max Tegmark, who told CNBC artificial general intelligence (AGI) is closer than we think and the narrative of a geopolitical battle between the U.S. and China racing to build the smartest AI is a "suicide race." While there is no singular definition of AGI, it is broadly taken to refer to AI that can outsmart humans. Applications like ChatGPT — that allow users to prompt a chatbot for answers — have exploded in popularity. But many AI companies are racing to develop the next level, with AI that has human-level intelligence. Sam Altman, the CEO of OpenAI, has said that AGI could be achieved by 2025. While there are other major names in the tech sector who also think AGI is close, many others think true AGI is still very far away . As well as competition between technology companies, there is also the geopolitical battle taking place between the U.S. and China for dominance in realms from AI to chips. While this is often portrayed as a race to be first to the latest technology, Tegmark said this is not the right framing. "I think of this battle, this geopolitical battle to build AGI first as a 'hopium war'," Tegmark told CNBC in an interview last month. " I call it the 'hopium war' because it's fueled by ... delusional hope that we can control AGI." Tegmark is the president of the Future of Life Institute, a thinktank which penned a letter last year calling for AI labs to pause the development of advanced AI systems . The letter was signed by major tech names including Tesla CEO Elon Musk . Tegmark's concern is that AI is advancing rapidly with very few guardrails in place, and no way to control it should it begin to outsmart humans. "We are much closer to building AGI than figuring out how to control it. And that means that the AGI race is not an arms race, it's a suicide race," Tegmark said. Is China worried about AGI? China has little incentive to build AGI, according to Tegmark. The AI scientist recalled a story in which Elon Musk told him about a "high level meeting" the Tesla boss had with Chinese government officials in early 2023. Musk said to the Chinese government that if AGI is built, China "will not be controlled by the Communist Party, but by the super intelligence," Tegmark said. "[Musk] got a very strong reaction. Some of them, really hadn't thought about that, and with less than a month from that, China came out with their first AI regulations," Tegmark said, referencing new regulation governing generative AI . China's ministry of foreign affairs was not immediately available for comment on the anecdote. CNBC also contacted Tesla for a response from Musk. "The U.S. doesn't need to convince China to not build AGI. Even if the U.S. didn't exist, the Chinese government would have an incentive to not build it because they want to be in control," Tegmark said. "[The] last thing they want is to lose that control." China's approach to AI AI is a strategic priority for the Chinese government. The country's biggest firms such as Alibaba , Huawei and Tencent have been developing their own AI models . The capabilities of those models are also advancing. China was also among the first countries in the world to bring in regulation around various aspects of AI . The country's internet is heavily censored and any information that appears to go against Beijing's ideology is blocked. OpenAI's ChatGPT is banned and it is well-noted that chatbots in China won't answer questions related to politics and topics deemed sensitive by the Communist Party. The country's approach to AI is therefore an attempt to push innovation while also balancing its own interests. When it comes to AGI, China is likely to pursue a similar approach, according to analysts. "I would not count on China to limit its own AI capabilities due to fears that such technologies would threaten Party rule. Similar predictions were made about the internet, they all proved to be false," Kendra Schaefer, a partner at consultancy Trivium China," told CNBC. "China will attempt to dominate AGI while creating a techno-regulatory apparatus that limits what AGI is permitted to do domestically." U.S.-China AI battle Despite Tegmark's view that the the race to build AGI is a "hopium war," geopoltiics remains front and center between the U.S. and China when it comes to development of the technology. "Right now, China is viewing AI through a dual-lens: geopolitical power and domestic growth," said Abishur Prakash, founder and geopolitical strategist at Toronto-based strategy advisory firm, The Geopolitical Business. watch now VIDEO 3:04 03:04 Underestimating China in the AI 'multi-decade arms race' would be a mistake Street Signs Asia "With AI, China hopes to shift the balance of power around the globe, like creating a new export model. And, in parallel, China wants to power its economy in new ways, from government efficiency to business applications," Prakash told CNBC. The U.S. has pursued a policy of attempting to restrict China's access to key technologies, mainly semiconductors like those designed by Nvidia , that are required to train more advanced AI models. China has responded by attempting to build its homegrown chip industry. Will the U.S. and China partner on AI rules? Technologists have warned of some of the risks and dangers when AGI does finally arrive. One theory is that without guardrails, AI will be able to improve itself and design new systems independently. Tegmark believes that any such risks will be realized by both the U.S. and China, which will force both countries' governments to individually come up with rules around AI safety. "So my optimistic path forward is the U.S. and China unilaterally impose national safety standards to prevent their own companies from doing harm and building uncontrollable AGI, not to appease the rivals superpowers, but just to protect themselves," Tegmark said. "After that happens though, there's this really interesting stage where the U.S. and China will be like, wait, how can we guarantee that North Korea doesn't build AGI or someone else? And then the U.S. and China have an incentive now to push the rest of the world to join them into an AGI moratorium." Indeed, governments are already trying to work together to figure out how to create regulations and frameworks around AI. Last year, the U.K. hosted an AI safety summit, which the U.S. and China were both in attendance, to discuss potential guardrails around the technology. But regulation and rules around AI are currently fragmented. This year, the European Union enacted the AI Act , the first major law globally governing the technology. China has its own set of rules, while many other countries have not yet moved to create any regulation. Tegmark's hope of co-ordination around AI safety is echoed by others. "When the dangers of competition are greater than the rewards, nations will ideally be motivated to come together and mutually self-regulate," Trivium China's Schaefer said. "Indeed, some Chinese policymakers have advocated for getting out ahead of that potential issue and establishing an international governance body under the UN – similar to the International Atomic Energy Agency – so there is desire on Beijing's side to establish a global governance body," she said.
NFL odds, Week 13 lines, ATS predictions, game picks, times, tips: Model simulates each game 10,000 timesHolden touts experience in NY-21 raceOWINGS MILLS, Md. (AP) — The biggest question facing the Baltimore Ravens right now has little to do with Lamar Jackson or even a defense that started the season poorly. It’s about a kicking conundrum that has turned into a crisis. Can the Ravens make it to the Super Bowl with Justin Tucker? One of the more surprising subplots of this NFL season has been Tucker’s decline from one of the greatest of all time to a week-in, week-out liability. Sunday’s loss to Philadelphia might have been the nadir — he missed two field goals and an extra point in a game the Ravens ultimately . “Points were at a premium in the game. They have been in a few of these games. Sometimes we haven’t made the most of our opportunity to score points,” coach John Harbaugh said Monday. “We’re racking our brains, talking to Justin, looking at what we’re doing. I’m very confident that it’s going to get fixed. I believe it will. It has to. “And he’s the guy to get it fixed.” Harbaugh has given every indication that he’s standing by Tucker, who is in his 13th season and is under contract through 2027. When he’s at his best, he’s the type of kicker that gives his team a clear advantage in close games, but this season he has missed eight field goals. Sunday showed that against a good defensive team, the Ravens (8-5) can’t simply assume their excellent offense will pile up points. There almost certainly will be close games in the weeks to come. Tucker’s ability to come through will be tested again, and for Baltimore to feel too confident at the moment. “When he was hitting, three or four years ago, hitting bombs, we were going 57, 58, 56 pretty regularly,” Harbaugh said. “That’s tightened up a little bit.” What’s working The Ravens continue to do a good job stopping the run. Although Saquon Barkley did eventually surpass the 100-yard mark late in the game, Baltimore held the Eagles to 140 yards on the ground, well below their usual output. What needs help Even beyond Tucker’s problems, Sunday wasn’t a great showing by Baltimore’s special teams. Tylan Wallace was shaky returning punts, and the Ravens had to start four drives inside their own 20 and two inside their own 10. “They had great bounces, and they downed right down in there,” Wallace said. “I’m pretty sure we’ll come back and talk about those and see what we can do to avoid those.” Stock up The Ravens’ defense continued to show signs of improvement, holding Philadelphia to 252 total yards. “I think we’ve just locked in on some things, and we’re playing our deep coverages better, bottom line,” Harbaugh said. “You watch the coverage, you watch the guys’ spacing, positioning, eyes, the communication, the checks that get made, and you just keep chasing doing the right things. It’s not (that we) changed the defense. We’re just playing it a lot better.” Stock down Harbaugh was vague on receiver Diontae Johnson’s situation. He was active Sunday but didn’t play, and he has only one catch in four games since the Ravens acquired him in a trade from Carolina. “I’m going to have to wait just to clarify it,” Harbaugh said. “There’s some moving parts there that we’re going to have to figure out and explore and just see where we’re at. I know that’s not the answer you want, but that’s the best I can do in fairness to everybody right now.” Injuries The Ravens were missing pass-rushing ace Kyle Van Noy (hamstring/neck) on Sunday, and WR Rashod Bateman was dealing with knee soreness. Key stats Through his first 12 seasons, Tucker made field goals at a 90% clip. That’s dropped to 70% this season. He had a 95% success rate from under 50 yards, and that’s dipped to 83%. Next steps The Ravens have this week off before a Dec. 15 road game against the New York Giants. Then comes a home matchup with Pittsburgh that may determine whether Baltimore has any shot to win the AFC North. ___ AP NFL:
Identity Verification Market to Grow by USD 16.92 Billion (2024-2028), Driven by eID Cards, Smart Infrastructure, and AI-Redefining Market Landscape - TechnavioJarrod Bowen held Antonio’s number nine shirt aloft after scoring the winner in support of the Hammers striker, who is recovering after a horror car crash on Saturday. Boss Julen Lopetegui said: “He is not in his best moment but he kept his humour. It was a special moment for us. “I think we have a lot of reason to win matches but this was one reason more. He’s alive so we are happy.” MA9 ❤️ pic.twitter.com/fXwtdSQWYE — West Ham United (@WestHam) December 9, 2024 West Ham players wore ‘Antonio 9′ shirts while warming up and walking out before kick-off. The shirts will be signed by the players, including Antonio, and auctioned off with the proceeds going to the NHS and Air Ambulances UK. Tomas Soucek headed West Ham into the lead and held up nine fingers to a TV camera. The Czech midfielder told Sky Sports: “He’s been here since I came here. He is really my favourite. I said it would be tough for me to play without him. "He was here since I came and he's really my favourite" Tomáš Souček on dedicating his goal to Michail Antonio ❤️ pic.twitter.com/smNy26wmuX — Sky Sports Premier League (@SkySportsPL) December 9, 2024 “I was so scared what was going to happen. It was a really tough week for him, his family and us.” Matt Doherty equalised for Wolves, and boss Gary O’Neil felt they should have had two penalties for fouls on Goncalo Guedes and Jean-Ricner Bellegarde, both of which were checked by VAR. But Bowen’s winner – O’Neil believed there was a foul in the build-up – condemned Wolves to a 10th defeat of the season and a third in a row. While under-pressure Lopetegui may have earned a stay of execution, O’Neil’s future as Wolves manager is now in serious doubt. “A lot of things went against us but ultimately we have not found a way to turn the game in our favour,” he said. “But the players showed they are still fighting for me, for the fans and the group. “Where does this leave me? In the same place I was. I’m aware of the noise. But if anyone expected this to be easy – I’m happy to be judged on results but it should be done in context. “Whenever this journey ends with Wolves I’ll be proud of it.” There was an acrimonious end to the match as captains Bowen and Mario Lemina scuffled after the final whistle, with the Wolves midfielder angrily shoving people including one of his own coaches, Shaun Derry. “I just went to shake his hand after the game,” Bowen said. “He didn’t want to shake my hand, two captains together just to say ‘well done’ after the game. “I know it’s difficult when you lose. I’ve been on the end of that situation.” O’Neil added: “Mario is calm now. He’s a passionate guy and something was said that upset him. “The instinct of the staff was to make sure he didn’t get into trouble, but he took some calming down.”
On November 22, 2024, a ceremony was held at Dalian Shipbuilding Industry Co., Ltd to mark that the newly built liquefied CO2 carrier “NORTHERN PIONEER” (the Vessel) is ready for delivery to Northern Lights JV DA (Northern Lights). The Vessel, which is engaged in the world’s first full-scale carbon capture and storage (CCS) value chain project, will be managed by “K” LINE LNG Shipping (UK) Ltd. based in London, the subsidiary of Kawasaki Kisen Kaisha, Ltd. (“K” LINE). It will transport liquefied CO2 from a CO2 capture facility in Norway to Northern Lights’ receiving terminal in Øygarden, western Norway. NORTHERN PIONEER “K” LINE and Northern Lights have entered into bareboat charter contracts and time charter contracts for three of the four vessels ordered by Northern Lights, including the Vessel. In line with “K” LINE Environmental Vision 2050, its long-term environmental policy, the “K” LINE group is actively promoting various initiatives aimed at supporting our own decarbonization efforts and those of society. “K” LINE aims to leverage the insights gained from our advanced liquefied CO2 transportation projects for the development of business in the future, thereby contributing to the realization of a sustainable society and enhancing corporate value. “This is a great moment for Northern Lights and the CCS industry. Today we celebrate that the full transport and storage chain of Northern Lights CO2 is ready. Northern Pioneer and her sister ships will enable flexible and scalable CO2 transport across Europe.”said Tim Heijn, Managing Director of Northern Lights. CEREMONY “We are delighted to have reached a significant milestone for the Northern Lights value chain, making the first step in our journey. With our extensive knowledge and experience in the operation of various liquefied gas carriers, the “K” LINE Group is determined to work together to contribute to Europe’s decarbonization through safe and reliable liquefied CO2 transportation.” said Yukikazu Myochin, President and CEO of “K” LINE. • Cargo Tank Capacity: 7,500 m3 • Overall length: 130 m • Breadth: 21 m • Cargo transport conditions: maximum pressure of 19 bar(g) pressure and minimum temperature of -35 °C • Primary fuel: LNG • Low-carbon technologies: Wind-assisted rotor sail and air lubrication Source: “K” Line
Suspect in UnitedHealthcare CEO killing charged with murder in New York, court records showTrump Tariff Shock Sparks All-Hands Response in Trudeau War Room
Suspect in UnitedHealthcare CEO killing charged with murder in New York, court records show
(Bloomberg) -- Asian stocks are set to follow the positive lead from Wall Street where a rally in the world’s largest technology companies drove stocks to fresh all-time highs. Futures show benchmarks in Tokyo, Shanghai and Sydney are set to rise at the open, while Hong Kong looks flat. Currency markets are in the spotlight, with the dollar snapping a three-day losing streak after President-elect Donald Trump’s warning to BRICS nations. French bonds and stocks came under renewed pressure while the euro fell as much as 1.1% amid the nation’s political turmoil. In the US, the S&P 500 notched its 54th closing record this year in a “narrow” advance that saw just a few groups ending higher. The tech-heavy Nasdaq 100 rose more than 1%, Tesla Inc. led gains in megacaps and Apple Inc. hit a fresh peak. Traders are bracing for a barrage of economic data and remarks from Federal Reserve speakers that will help shape the outlook for interest rates. Treasuries pared losses on Monday after Fed Governor Christopher Waller said he’s inclined to vote for a rate cut in December, with swaps pricing in more than 70% of a quarter-point cut this month. The highlight this week is Friday’s payrolls report, which is expected to show US hiring jumped in November after hurricanes and a major strike undercut job growth a month earlier. On Wednesday, Fed Chair Jerome Powell participates in a moderated discussion, and investors will await any assessment of the job market and inflation as well as clues to whether the central bank will lower rates in December. “This week is the last truly important economic data week of 2024,” said Tom Essaye at The Sevens Report. “If results are ‘Goldilocks,’ then investors will expect a soft landing and a December rate cut.” The S&P 500 added 0.2%. The Nasdaq 100 rose 1.1%. The Dow Jones Industrial Average fell 0.3%. Treasury 10-year yields advanced two basis points to 4.19%. In a move that escalated a campaign to contain Beijing’s technological ambitions, but stopped short of earlier proposals that would have sanctioned more key Chinese firms, the US unveiled new restrictions on China’s access to vital components for chips and AI. The Department of Commerce slapped fresh curbs on the sale of high-bandwidth memory chips made by US and foreign companies, likely affecting South Korea’s SK Hynix Inc. and Samsung Electronics Co. as well as Idaho-based Micron Technology Inc. In China, investors hungry for signs of stimulus to boost the sub-par economy have been put on edge after the Communist Party’s elite decision-making body skipped releasing a readout for its regular November meeting. Investors are now turning their attention to this month’s Politburo assembly — one of three annually to normally focus on economic policy. In Europe, Marine Le Pen pledged to topple Prime Minister Michel Barnier’s government after he failed to meet her demands on a new budget, threatening financial and political disruption for France. Buoyant Mood Back on Wall Street, the mood remains buoyant. The Fed’s Waller said he’s inclined to vote for another reduction in interest rates when officials meet later this month, though data due before then could make the case for holding them steady. The optimism is in stark contrast to a year ago, when equity investors and strategists were bracing for a potentially turbulent 2024, worrying about the risk of a hard landing for the US economy and rate cuts that could come too late to prevent it. Few anticipated that the S&P 500’s annual gain would be among the best in history. “We now find ourselves in the middle of this ‘Goldilocks’ zone, where economic health supports earnings growth while remaining weak enough to justify potential Fed rate cuts,” said Mark Hackett at Nationwide. “December continues the seasonal tailwind, historically delivering the second-best performance behind November. Other technical tailwinds for the market include financial conditions, sentiment, momentum, and breadth.” December has usually been a stronger month when the market enters the month up solidly year-to-date, according to Bespoke Investment Group. In the 22 years that the S&P 500 has been up more than 20% in the year through November, the index has averaged a gain of 1.77% in December — with positive returns 77.3% of the time, Bespoke noted. While the gauge has fallen in December just five of 22 times when it has been up over 20% through November, three of those five December drops came during election years (1936, 1980, 1996). Corporate Highlights: Key events this week: Some of the main moves in markets: Stocks Currencies Cryptocurrencies Bonds More stories like this are available on bloomberg.com ©2024 Bloomberg L.P.Seahawks have taken a bumpy path to first place in the NFC West
Legislature plans to increase experience for new lawmakers ahead of term-limit turnover
NoneNASHUA, N.H., Nov. 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc . ICAD ("iCAD" or the "Company"), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast health AI technologies at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, December 1-5. Key highlights include the recent FDA-cleared ProFound Detection Version 4, clinical research presentations, and a new partnership with Cascaid Health to expand access to AI-driven breast health solutions. iCAD and Cascaid Health Partner to Expand Access to AI-Driven Breast Health In alignment with their vision to enable all women to access to AI-powered breast health services, iCAD and Cascaid Health will unveil their collaboration to integrate the ProFound AI Breast Health Suite into Cascaid's leading edge digital health marketplace and access to care platform. Scheduled for beta launch in Q1 2025, this partnership between iCAD and Cascaid Health will launch ProFound Health, a virtual care model powered by Cascaid. ProFound will enable women who have not otherwise received an AI-read on their screening mammogram to access iCAD's advanced breast health technology. The initiative reflects both companies' dedication to democratizing access to life-saving technology and creating a world where cancer can't hide. ProFound Health will offer a "Second Read" virtual AI service, providing patients without access to AI an opportunity to receive enhanced breast health insights. The initial service will include second-read detection, breast density assessment, and cancer risk evaluation from a Cascaid-affiliated specialist network of clinical experts in women's health through Cascaid's seamlessly integrated digital platform. By combining AI insights with expert clinical reviews, ProFound Health ensures that patients everywhere, regardless of location, can receive precision screening and personalized care. "ProFound Health empowers patients with access to critical information about their mammograms and overall breast health, allowing them to make informed decisions and take control of their care journey," said Dana Brown, CEO and President of iCAD. "Our collaboration with Cascaid Health's network of clinicians and AI-powered solutions is part of our ongoing commitment to bridging gaps in breast cancer care, ensuring all patients everywhere can access the accuracy and timeliness of AI solutions, and ultimately transforming patient outcomes." "We believe that every woman should have access to the best possible information about her breast health and a high quality, personalized care plan to catch cancer early or prevent it altogether. Through our partnership with iCAD, we're addressing a critical need to improve access to advanced breast health services," said Dr. Candace Westgate, Director of Women's Health for Cascaid Health. "ProFound Health is more than just a technological innovation, it's a lifeline that empowers patients and healthcare providers with actionable insights, bridging care gaps and ensuring equitable access to precision screening and personalized breast cancer care." Advancing Next Generation AI Breast Health Solutions at RSNA 2024 In addition to ProFound Health, iCAD will feature its flagship ProFound Detection Version 4.0, which recently received FDA clearance. This next-generation AI solution enhances breast cancer detection by incorporating prior exams into current analysis, improving the detection of aggressive cancers by 22%, reducing cases with no marks by 18%, and providing clinicians with more reliable insights for better decision-making. "Every two minutes, someone loses their life to breast cancer—a disease affecting over 2.3 million women annually. Early detection is critical, as five-year survival rates exceed 99% for stage 1 disease. Yet traditional mammography misses over 20% of breast cancers, particularly in dense tissue, resulting in potentially avoidable late-stage diagnoses," said Dana Brown, President and CEO of iCAD, Inc. "ProFound Detection Version 4 revolutionizes breast cancer detection by uniquely integrating prior exams into its analysis. This advanced capability enhances sensitivity, sharpens precision, and provides radiologists with a deeper, longitudinal view of a patient's breast health. By enabling earlier and more accurate detection, especially in dense tissue, ProFound Detection Version 4 sets a new standard in breast health AI, empowering providers to improve outcomes and save lives. Together with our strategic partnerships, we are advancing the fight against cancer and making a meaningful difference for patients worldwide." ICAD'S RSNA 2024 Program Highlights AI-Powered Insights: Advancing Cancer Detection Oral Abstract Presentation : "Real World Effect of Artificial Intelligence on Histopathology and Stage in Breast Cancer Screening" Presenter : Kathy Schilling, M.D., Boca Raton Regional Hospital When : Sunday, December 1 | 10:30–11:30 AM Where : S406A: S2-SSBR01-6 Details : Dr. Kathy Schilling discusses the experience with tenured radiologists on how the current use of ProFound AI improves cancer detection, even in women with dense breast tissue, compared to their performance prior to the implementation of AI. In addition, she will describe the decrease in the mean size and stage of cancers after the implementation, along with an increase in the diagnosis of lobular cancers. "The integration of ProFound AI alongside our nine dedicated breast radiologists has demonstrated remarkable improvements in cancer detection and patient outcomes across our imaging network," said Dr. Kathy Schilling, Medical Director of the Christine E. Lynn Women's Health & Wellness Institute at Boca Raton Regional Hospital. "We've seen a 23% overall increase in cancer detection rates, a 4% rise in invasive cancer detection, and doubled rates of lobular cancer detection. ProFound AI also enhanced detection in dense breast tissue by 32%, reduced invasive cancer size by 12%, and lowered histopathologic stage with a 40% reduction in T2 tumors—all without increasing DCIS diagnoses or recall rates. These advancements underscore the transformative potential of AI in improving early breast cancer detection, elevating patient care, and ultimately saving lives." AI Theater Presentation : "The Thin White Line: Which Calcifications Matter? Advances in AI Breast Cancer Detection" Presenter : Chirag R. Parghi, M.D., M.B.A., Solis Mammography When : Tuesday, December 3 | 1:00–1:20 PM Where : AI Showcase Theater (South Hall A), Booth 5536 Details : A look at how ProFound Detection's next-generation capabilities reduce uncertainty in interpreting calcifications on a mammogram by displaying 20% fewer marks related to vascular calcifications and 51% fewer marks related to non-vascular calcifications, leading to enhanced precision and accuracy. Collaborative Panels and Partner Showcases GE HealthCare Expert Corner : Seamless integration of ProFound AI with GE mammography systems to enhance workflow and detection capabilities. Daily at Booth 7330 (North Hall). Densitas Panel : "Elevating Patient Care through Quality Images & Precise Detection." Daily at Booth 4747 (South Hall). CancerIQ : Daily at Booth 4747(South Hall). Blackford Panel : "Enhancing Breast Cancer Care with AI." Tuesday, December 3, 2:30-2:50 PM at Booth 4729 (South Hall). CARPL.ai Breast AI Panel : Wednesday, December 4, 11:00 AM at Booth 5733 (South Hall). Customer Appreciation Event iCAD will be hosting a customer appreciation event, "AI in the Sky: Discover ProFound Insights & Breast Health Innovations," on Sunday, December 1, at 6:00 PM at VU Rooftop in Chicago. Network with industry experts, hear insights from key opinion leaders including iCAD's CEO and Board of Directors, and explore how iCAD's solutions are transforming breast health. Visit the iCAD RSNA 2024 event page for the latest updates, event details, and partnership announcements. About Cascaid Health Cascaid Health Inc. delivers a personalized, expert-driven proactive and preventative approach, supported by an integrated platform designed to promote longevity, detect issues early, reverse risks, and optimize healthspan for all. The company's platform offers a curated marketplace featuring innovative products, services, and access to world-class multidisciplinary experts in women's health, precision health, lifestyle medicine, wellness, and performance. Cascaid Health Inc. is committed to advancing health equity, ensuring that cutting-edge healthcare solutions are accessible to everyone. About iCAD, Inc. iCAD, Inc. ICAD is a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes. Headquartered in Nashua, N.H., iCAD's industry-leading ProFound Breast Health Suite provides AI-powered mammography analysis for breast cancer detection, density assessment and risk evaluation. Used by thousands of providers serving millions of patients, ProFound is available in over 50 countries. In the last five years alone, iCAD estimates reading more than 40 million mammograms worldwide, with nearly 30% being tomosynthesis. For more information, including the latest in regulatory clearances, please visit www.icadmed.com . Forward-Looking Statements Certain statements contained in this News Release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the expansion of access to the Company's products, improvement of performance, acceleration of adoption, expected benefits of ProFound AI®, the benefits of the Company's products, and future prospects for the Company's technology platforms and products. Such forward-looking statements involve a number of known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited, to the Company's ability to achieve business and strategic objectives, the willingness of patients to undergo mammography screening, whether mammography screening will be treated as an essential procedure, whether ProFound AI will improve reading efficiency, improve specificity and sensitivity, reduce false positives and otherwise prove to be more beneficial for patients and clinicians, the impact of supply and manufacturing constraints or difficulties on our ability to fulfill our orders, uncertainty of future sales levels, to defend itself in litigation matters, protection of patents and other proprietary rights, product market acceptance, possible technological obsolescence of products, increased competition, government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company; and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe," "demonstrate," "intend," "expect," "estimate," "will," "continue," "anticipate," "likely," "seek," and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at https://www.icadmed.com and on the SEC's website at http://www.sec.gov . CONTACTS Media Inquiries: pr@icadmed.com Investor Inquiries: John Nesbett/Rosalyn Christian IMS Investor Relations icad@imsinvestorrelations.com © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.